Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 16, 2019)
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2020 and as adjusted based on a specified fee schedule factor in each year thereafter.
What just happenedJul 17, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 16, 2019
- Jul 17, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 16, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 16, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 16, 2019IntroReferralIntro-H
Introduced in House
- Jul 16, 2019IntroReferral1000
Introduced in House